LETIPharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company. Since its creation, in 1919, LETIPharma has been working in immunotherapy based on the use of allergens, applying principals of personalized medicine, and a patient approach keeping with the “One Health” philosophy. LETIPharma integrates two lines of business, and several areas of work: HUMAN HEALTH - Immunology and Allergy, centered on the production of allergen extracts for allergy diagnosis and treatment. - Dermatology and skin care, which centers its activity on the development of dermo-pharmaceutical products as well as other special products designed for personal care and treatment of skin abnormalities. ANIMAL HEALTH A line specialized in producing solutions for Veterinary Immunology and Dermatology for the prevention, diagnosis and treatment of the major immune-mediated diseases found in pets, like allergy and leishmaniasis. LETIPharma is a Spanish multinational with solid international presence.
Looking for a particular Laboratorios LETI employee's phone or email?
The Laboratorios LETI annual revenue was $9.1 million in 2026.
Fabio Ferraro is the CTO of Laboratorios LETI.
332 people are employed at Laboratorios LETI.
Laboratorios LETI is based in Barcelona, Catalonia.
The NAICS codes for Laboratorios LETI are [3254, 32, 32541, 325].
The SIC codes for Laboratorios LETI are [283, 2834, 28].